Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Impax Labs Inc (IPXL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart
Realtime quote and/or trade prices are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,256,165
  • Shares Outstanding, K 74,110
  • Annual Sales, $ 824,430 K
  • Annual Income, $ -472,030 K
  • 36-Month Beta 0.99
  • Price/Sales 1.51
  • Price/Cash Flow 7.24
  • Price/Book 2.59

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.93 +7.06%
on 11/09/17
19.95 -14.54%
on 10/26/17
-2.85 (-14.32%)
since 10/24/17
3-Month
15.93 +7.06%
on 11/09/17
25.70 -33.66%
on 09/21/17
-1.00 (-5.54%)
since 08/24/17
52-Week
7.75 +120.00%
on 03/07/17
25.70 -33.66%
on 09/21/17
+2.60 (+17.99%)
since 11/23/16

Most Recent Stories

More News
Lifshitz & Miller LLP Announces Investigation of CBBC Bancorp, Clifton Bancorp Inc., Dynegy, Inc., GenMark Diagnostics, Inc., Impax Laboratories, Inc., RPM International Inc. and XBiotech Inc.

CBBC Bancorp (CBBC)

GNMK : 4.65 (+0.22%)
CSBK : 17.03 (+0.24%)
DYN : 12.42 (-0.56%)
IPXL : 17.05 (+0.59%)
SBKK : 11.4000 (+0.44%)
XBIT : 4.13 (+3.25%)
RPM : 52.30 (+0.13%)
CBBC : 24.2500 (+0.37%)
Technical Snapshots for These Drug Makers Stocks -- AstraZeneca, Impax Laboratories, TherapeuticsMD, and GlaxoSmithKline

If you want a Stock Review on AZN, IPXL, TXMD, or GSK then come over to http://dailystocktracker.com/register/ and sign up for your free customized report. Drug Manufacturers companies develop and sell...

AZN : 33.84 (+0.03%)
IPXL : 17.05 (+0.59%)
TXMD : 5.99 (-0.99%)
GSK : 35.04 (-0.06%)
Impax (IPXL) Q3 Earnings & Revenues Beat Estimates, Fall Y/Y

Impax (IPXL) reported dismal third-quarter results with earnings and sales coming in lower than the year-ago period. However, the company beat estimates on both counts.

JNJ : 138.01 (+0.52%)
IPXL : 17.05 (+0.59%)
NVS : 85.08 (+0.71%)
SNY : 46.10 (+1.61%)
Impax Reports Third Quarter 2017 Results

Impax Laboratories, Inc. (NASDAQ: IPXL), today announced third quarter 2017 financial results.

IPXL : 17.05 (+0.59%)
Impax Laboratories Mourns the Passing of Board Member Richard A. Bierly

Impax Laboratories, Inc. (NASDAQ: IPXL) is mourning the loss of Richard A. Bierly, a member of the Impax Board of Directors, who recently passed away. Appointed in August 2016, Richard also served on the...

IPXL : 17.05 (+0.59%)
MDVN : 81.48 (+0.05%)
New Research: Key Drivers of Growth for Coty, Bristol-Myers Squibb, Carnival, Agenus, Steel Dynamics, and Impax Labs - A Look Behind the Scenes at Consolidated Results, Factors of Influence, Major Initiatives and Sustained Production

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Coty Inc. (NYSE:COTY), Bristol-Myers...

AGEN : 3.92 (-2.49%)
IPXL : 17.05 (+0.59%)
CCL : 66.71 (-0.12%)
COTY : 17.00 (+0.12%)
BMY : 61.43 (+0.47%)
STLD : 37.49 (-0.61%)
Impax Announces Consent Solicitation

Impax Laboratories, Inc. (NASDAQ: IPXL), a specialty pharmaceutical company ("Impax" or the "Company"), announced today the commencement of a consent solicitation with respect to its 2.00% Convertible...

IPXL : 17.05 (+0.59%)
WeissLaw LLP Investigates Impax Laboratories, Inc. Acquisition

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Impax Laboratories, Inc. ("IPXL" or the "Company") (NASDAQ: IPXL) in connection...

IPXL : 17.05 (+0.59%)
Wolf Popper LLP Investigates the Proposed Acquisition of Impax Laboratories, Inc. by Amneal Pharmaceuticals LLC

Wolf Popper LLP is investigating claims on behalf of investors in Impax Laboratories, Inc. (NASDAQ: IPXL), concerning the all-stock proposed acquisition of Impax by Amneal Pharmaceuticals LLC, a private...

IPXL : 17.05 (+0.59%)
Impax Announces FDA Approval and Launch of Generic Renvela® (Sevelamer Carbonate) Tablets, 800 mg

Impax Laboratories, Inc. (NASDAQ: IPXL), a specialty pharmaceutical company, today announced it has received final U.S. Food and Drug Administration ("FDA") approval on its Abbreviated New Drug Application...

IPXL : 17.05 (+0.59%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators mostly agree with the trend.

See More

Business Summary

Impax Laboratories, Inc. is a technology-based, specialty pharmaceutical company engaged in the development, manufacture, and marketing of specialty prescription pharmaceutical products utilizing its own formulation expertise and drug delivery technologies. IMPAX Laboratories is focusing on two key areas,...

See More

Key Turning Points

2nd Resistance Point 17.38
1st Resistance Point 17.22
Last Price 17.05
1st Support Level 16.92
2nd Support Level 16.78

See More

52-Week High 25.70
Fibonacci 61.8% 18.84
Last Price 17.05
Fibonacci 50% 16.73
Fibonacci 38.2% 14.61
52-Week Low 7.75

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart